SOCIETAL VIEWS ON NICE, CANCER DRUGS FUND AND VALUE-BASED PRICING CRITERIA FOR PRIORITISING MEDICINES: A CROSS-SECTIONAL SURVEY OF 4118 ADULTS IN GREAT BRITAIN

ABSTRACT The criteria used by the National Institute for Health and Clinical Excellence (NICE) for accepting higher incremental cost‐effectiveness ratios for some medicines over others, and the recent introduction of the Cancer Drugs Fund (CDF) in England, are assumed to reflect societal preferences...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Health economics 2013-08, Vol.22 (8), p.948-964
Hauptverfasser:	Linley, Warren G., Hughes, Dyfrig A.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Aged Antineoplastic Agents - economics Antineoplastic Agents - therapeutic use Attitude to Health Cancer cancer drugs fund Cost-Benefit Analysis - economics Cost-Benefit Analysis - statistics & numerical data Cross-Sectional Studies Data Collection Decision analysis Drug Costs - statistics & numerical data Drugs equity Federal funding Female Funds Health Health care policy health care rationing Health economics Health Priorities - economics Health Priorities - statistics & numerical data Humans Male Middle Aged NICE orphan drugs Preferences Prescription drugs Pricing public preferences Resource allocation Resource Allocation - economics Resource Allocation - methods Studies Surveys and Questionnaires United Kingdom - epidemiology value-based pricing Value-Based Purchasing - statistics & numerical data Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!